HealthcareBiotech & Life SciencesData & AnalyticsInsuranceDeveloper ToolsCybersecurityInfrastructure & CloudAIFintech
AV8 Ventures is an Allianz-backed early-stage venture capital firm that focuses on Seed and Series A investments in healthcare, enterprise software, financial services/insurtech, and deep technology. The firm's strategy involves partnering with visionary founders to build category-defining companies, offering both capital and strategic support to help them achieve product-market fit and scale.
Their most common stage is seed (47% of deals). Average disclosed round size is $27.5M (across 15 rounds with reported amounts).
Portfolio
15
Fund Size
$360M
Top Stage
Seed
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Think Bioscience | Series A | $55M | Jan 2026 |
 Hydrolix | Series C | $80M | Apr 2025 |
 Cerby | Series A | $17M | Aug 2023 |
 Glow | Series A | $22.5M | Nov 2022 |
 CoverTree | Seed | $10M | Sep 2022 |
| Think Bioscience | Seed | $17M | Aug 2022 |
 WAX Insurance Services | Seed | $10M | May 2022 |
 Embrace | Series B | $45M | Oct 2021 |
| AAlpha Medical | Series B | $24M | Sep 2021 |
 Uizard | Series A | $15M | Aug 2021 |
| Hydrolix | Seed | $10M | Feb 2021 |
 DELFI Diagnostics, Inc. | Series A | $100M | Jan 2021 |
 Rephrase.ai | Seed | $1.5M | Sep 2020 |
| Uizard | Seed | $2.8M | Sep 2019 |
| PPlentina | Seed | $2.2M | — |
Top Co-Investors
Wing2 shared
Innovation Endeavors2 shared
Buff Gold Ventures2 shared
byFounders2 shared
LDV Capital2 shared
Founders Fund2 shared
QED Investors1 shared
Sozo Ventures1 shared
Frontline Ventures1 shared
Blumberg Capital1 shared
Uncorrelated Ventures1 shared
Ericsson1 shared
Nava1 shared
Oregon Venture Fund1 shared
Silicon Valley Data Capital1 shared
Samsung Next1 shared
GSR Ventures1 shared
Slow Ventures1 shared
Janus Henderson Investors1 shared
MBX Capital1 shared
Last updated: 16 April 2026